Company Filing History:
12 out of 504 
2 out of 512 
Years Active: 2016-2025
Title: The Innovative Contributions of Xingxing Zang
Introduction
Xingxing Zang is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of immunotherapy. With a total of 12 patents to his name, Zang has made remarkable strides in developing novel treatments for cancer and other diseases.
Latest Patents
Among his latest patents are BTNL9 and ERMAP, which serve as novel inhibitors of the immune system for immunotherapies. These patents provide methods for treating tumors in subjects using BTNL9-binding and ERMAP-binding antibodies. Additionally, Zang has developed a fusion protein comprising BTNL9 or ERMAP, along with related compositions and encoding nucleic acids. Another notable patent involves monoclonal antibodies that target the IgV domain of B7-H3, offering methods for treating cancer and infections, as well as imaging B7-H3 positive cells.
Career Highlights
Zang has worked at prestigious institutions such as the Albert Einstein College of Medicine and the Sloan Kettering Institute for Cancer Research. His work in these organizations has allowed him to advance his research and contribute to groundbreaking discoveries in cancer treatment.
Collaborations
Zang has collaborated with notable figures in the field, including James P. Allison and Jordan M. Chinai. These partnerships have further enhanced his research and innovation in immunotherapy.
Conclusion
Xingxing Zang's innovative work and numerous patents highlight his dedication to advancing medical science, particularly in the realm of cancer treatment. His contributions continue to pave the way for new therapeutic approaches that could significantly impact patient care.